Documents

Documents

Reports on the status of patients with COVID-19, methods of treatment, potential drugs, laboratory tests, epidemiological forecasts and much more.

CategoryTitleSourcePreprintPublicatedAddedLocationDownload documentTags Listdocument_category_hfilterdocument_source_hfilterdocument_locale_hfilterdocument_preprint_hfilter
Epidemiology, Health and safety precautions, Personal protective equipmentPersistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agentsScienceDirectPeer-reviewed02/06/202003/06/2020 09:20 antimicrobial productsantiseptichygieneInactivationPPEepidemiology health-and-safety-precautions personal-protective-equipmentsciencedirectpeer-reviewed
Promising drugs and vaccines, TreatmentChloroquine and hydroxychloroquine as available weapons to fight COVID-19ScienceDirectPreprint03/04/202003/06/2020 08:05 antiviralchloroquineclinical trialslaboratory resultsstatistictreatmentpromising-drugs-and-vaccines treatmentsciencedirectpreprint
Promising drugs and vaccines, TreatmentSARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorScienceDirectPreprint03/05/202003/06/2020 07:59 ACE2antivirallaboratory trialsschemeserine proteaseTMPRSS2treatmentviral entrypromising-drugs-and-vaccines treatmentsciencedirectpreprint
Epidemiology, Health and safety precautions, Personal protective equipmentDisinfectants for Use Against SARS-CoV-2EPAPeer-reviewed03/03/202003/06/2020 07:56USA antimicrobial productsdisinfectantshygienePPEepidemiology health-and-safety-precautions personal-protective-equipmentepausapeer-reviewed
Pathology, Patient reportsClinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaSpringerLinkPeer-reviewed03/03/202003/06/2020 07:51China, Hubei, Wuhan clinical featureslaboratory resultsmortalityschemesigns and symptomsstatistictimeline chartsWuhanpathology patient-reportsspringerlinkchina hubei wuhanpeer-reviewed
Patient reportsEpidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contactsmedRxivPreprint03/04/202003/05/2020 18:24China, Shenzhen clinical featuresepidemiologylaboratory resultssigns and symptomsstatistictimeline chartstransmissionpatient-reportsmedrxivchina shenzhenpreprint
Patient reports, Testing and PCRPositive RT-PCR Test Results in Patients Recovered From COVID-19JAMA NetworkPeer-reviewed02/27/202003/05/2020 16:00China, Hubei, Wuhan antiviralBioGermoseltamivirrecoveredRT-PCRtest kitstreatmentpatient-reports testing-and-pcrjama-networkchina hubei wuhanpeer-reviewed
Patient reportsEpidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in SingaporeJAMA NetworkPeer-reviewed03/03/202003/05/2020 15:54Singapore antiviralclinical featuresepidemiologykaletralaboratory resultslopinavir/ritonaviroxygen therapysigns and symptomsSingaporestatistictimeline chartstreatmentpatient-reportsjama-networksingaporepeer-reviewed
Patient reportsAnalysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus diseaseCMJPreprint02/28/202003/05/2020 15:48China, Hubei, Wuhan clinical featurescomorbiditylaboratory resultsmeta-analysispneumoniasigns and symptomsstatisticpatient-reportscmjchina hubei wuhanpreprint
Promising drugs and vaccinesTherapeutic effects of dipyridamole on COVID-19 patients with coagulation dysfunctionmedRxivPreprint02/29/202003/05/2020 15:42 clinical featuresclinical trialscoagulation dysfunctionCTD-dimerdipyridamolehistologylaboratory resultsRT-PCRschemesigns and symptomstimeline chartstreatmentpromising-drugs-and-vaccines treatmentmedrxivpreprint
Current treatment experienceCOVID-19: combining antiviral and anti-inflammatory treatmentsThe LancetPeer-reviewed02/27/202003/05/2020 15:37 anti-inflammatoryantiviralBaricitinibFedratinibRuxolitinibtreatmentcurrent-treatment-experience treatmentthe-lancetpeer-reviewed
Promising drugs and vaccinesConvalescent plasma as a potential therapy for COVID-19The LancetPreprint02/27/202003/05/2020 15:34 convalescent plasmamonoclonal antibodiesplasmatreatmentpromising-drugs-and-vaccines treatmentthe-lancetpreprint
Promising drugs and vaccinesThalidomide Combined with Low-dose Glucocorticoid in the Treatment of COVID-19 PneumoniaPreprints.orgPreprint02/26/202003/05/2020 15:25 clinical featurescorticosteroidsCTlaboratory resultspneumoniaschemesigns and symptomsstudyThalidomidetimeline chartstreatmentpromising-drugs-and-vaccines treatmentpreprints-orgpreprint
Current treatment experienceEfficacies of lopinavir/ritonavir and abidol in the treatment of novel coronavirus pneumoniaCDAPreprint02/24/202003/05/2020 15:17 antiviralarbidolclinical trialsinterferon alphakaletralopinavir/ritonavirtreatmentcurrent-treatment-experience treatmentcdapreprint
Promising drugs and vaccinesProtection of Rhesus Macaque from SARS-Coronavirus challenge by recombinant adenovirus vaccinemedRxivPreprint02/21/202003/05/2020 15:13 adenovirushistologylaboratory trialsschemestudytreatmentvaccinepromising-drugs-and-vaccines treatmentmedrxivpreprint
Pathology, Patient reportsChest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of InfectionRSNAPeer-reviewed02/20/202003/04/2020 21:49China clinical featuresCTlaboratory resultspneumoniaRT-PCRsigns and symptomspathology patient-reportsrsnachinapeer-reviewed
Promising drugs and vaccinesBreakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studiesBSTPreprint02/19/202003/04/2020 21:46 antiviralchloroquineclinical trialstreatmentpromising-drugs-and-vaccines treatmentbstpreprint
Pathology, Patient reportsLongitudinal CT Findings in COVID-19 Pneumonia: Case Presenting Organizing Pneumonia PatternRSNAPeer-reviewed02/14/202003/04/2020 21:36China, Hubei, Wuhan clinical featuresCTlaboratory resultsoseltamivirpneumoniasigns and symptomspathology patient-reportsrsnachina hubei wuhanpeer-reviewed
Promising drugs and vaccinesA randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumonia (COVID-19)ChiCTR02/14/202003/04/2020 21:32 antiviralclinical trialsRemdesivirtreatmentpromising-drugs-and-vaccines treatmentchictr
Promising drugs and vaccinesProphylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infectionPNASPeer-reviewed02/13/202003/04/2020 21:28 animal modelantiviralchartsclinical trialshistologyMERSRemdesivirschemetimeline chartstreatmentpromising-drugs-and-vaccines treatmentpnaspeer-reviewed
Promising drugs and vaccinesPotential interventions for novel coronavirus in China: A systematic reviewJMVPreprint02/13/202003/04/2020 21:20 antiviralgeneral treatmentimmunoenhancersmonoclonal antibodiestreatmentvitaminspromising-drugs-and-vaccines treatmentjmvpreprint
Pathology, Patient reportsCardiac Implications of Novel Wuhan Coronavirus (COVID-19 )AACPeer-reviewed02/07/202003/04/2020 21:02 cardiac implicationscardiovascularclinical featurescomorbiditydiabeticsinfluenzaMERSmortalityprognosisSARS-CoVsigns and symptomsstatisticpathology patient-reportsaacpeer-reviewed
Current treatment experienceOn the use of corticosteroids for 2019-nCoV pneumoniaThe LancetPeer-reviewed02/11/202003/04/2020 20:57 corticosteroidsinfluenzamortalitySARS-CoVtreatmentcurrent-treatment-experience treatmentthe-lancetpeer-reviewed
Current treatment experienceClinical evidence does not support corticosteroid treatment for 2019-nCoV lung injuryThe LancetPeer-reviewed02/07/202003/04/2020 20:51 ARDScorticosteroidsinfluenzaMERSRSVSARS-CoVseptic shocktreatmentcurrent-treatment-experience treatmentthe-lancetpeer-reviewed
Current treatment experienceReducing mortality from 2019-nCoV: host-directed therapies should be an optionThe LancetPeer-reviewed02/05/202003/04/2020 20:45 antiviralcyclosporinekaletralopinavir/ritonavirmonoclonal antibodiesRemdesivirTocilizumabtreatmentcurrent-treatment-experience treatmentthe-lancetpeer-reviewed
Promising drugs and vaccinesBaricitinib as potential treatment for 2019-nCoV acute respiratory diseaseThe LancetPeer-reviewed02/03/202003/04/2020 20:42 ACE2antiviralBaricitinibtreatmentpromising-drugs-and-vaccines treatmentthe-lancetpeer-reviewed
Promising drugs and vaccinesStudy for the efficacy of chloroquine in patients with novel coronavirus pneumonia (COVID-19)ChiCTRPreprint02/03/202003/04/2020 20:38China antiviralchloroquineclinical trialsstudytreatmentpromising-drugs-and-vaccines treatmentchictrchinapreprint
Promising drugs and vaccinesRemdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroThe NaturePeer-reviewed04/02/202003/04/2020 20:35 antiviralchloroquineRemdesivirschemetreatmentpromising-drugs-and-vaccines treatmentthe-naturepeer-reviewed
Promising drugs and vaccinesChemotherapeutic Strategy with Synbiotics, Thalidomide and Celecoxib for severe COVID-19 Pneumonia. Association between microbiota, chronic inflammation and pneumoniaResearchGatePreprint03/04/202003/04/2020 20:28 Celecoxibchemotherapychronic inflammationmicrobiotaSynbioticsThalidomideTLRstreatmentpromising-drugs-and-vaccines treatmentresearchgatepreprint
Current treatment experienceClinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspectedWHOPeer-reviewed01/28/202003/04/2020 20:20 ARDScomplicationscorticosteroidsECLSendotracheal intubationmechanical ventilationmonitoringnon-invasive ventilationoxygen therapypregnancypregnantseptic shocksupportive therapytreatmentcurrent-treatment-experience treatmentwhopeer-reviewed
Promising drugs and vaccinesZn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell CulturePLOSPeer-reviewed11/04/201003/04/2020 20:12 antiviralEAVSARS-CoVschemetreatmentzincumpromising-drugs-and-vaccines treatmentplospeer-reviewed
Promising drugs and vaccinesAntiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn MiceASMPeer-reviewed07/17/200903/04/2020 20:07 antiviralchloroquineHCoV-OC43SARS-CoVschemetreatmentpromising-drugs-and-vaccines treatmentasmpeer-reviewed
Promising drugs and vaccinesChloroquine is a potent inhibitor of SARS coronavirus infection and spreadVirology JournalPeer-reviewed08/22/200503/04/2020 20:01 ACE2antiviralchloroquineSARS-CoVschemetreatmentpromising-drugs-and-vaccines treatmentvirology-journalpeer-reviewed
Promising drugs and vaccinesEffects of chloroquine on viral infections: an old drug against today’s diseasesThe LancetPeer-reviewed11/03/200303/04/2020 19:55 antiviralchloroquineHIVSARS-CoVschemetreatmentpromising-drugs-and-vaccines treatmentthe-lancetpeer-reviewed
Pathology, Patient reportsCT Imaging of the 2019 Novel Coronavirus (2019-nCoV) PneumoniaRSNAPeer-reviewed01/31/202003/04/2020 19:29China, Hubei, Wuhan clinical featuresCTinterferonJanuarylaboratory resultspneumoniasigns and symptomspathology patient-reportsrsnachina hubei wuhanpeer-reviewed
Pathology, Patient reportsHeart injury signs are associated with higher and earlier mortality in coronavirus disease 2019 (COVID-19)medRxivPreprint02/29/202003/04/2020 19:24China, Hubei, Wuhan ACE2chartsclinical featurescomorbidityFebruaryheartheart injurylaboratory resultsprognosissigns and symptomsstatistictimeline chartspathology patient-reportsmedrxivchina hubei wuhanpreprint
Pathology, Patient reportsCOVID-19 outbreak increased risk of schizophrenia in aged adultsChinaXivPreprint02/29/202003/04/2020 19:14China, Jiangsu, Xuzhou chartsclinical featurescomorbidityFebruarymental disordersrisk factorschizophreniasigns and symptomsstatisticpathology patient-reportschinaxivchina jiangsu xuzhoupreprint
Pathology, Patient reportsClinical Features of COVID-19 Related Liver DamagemedRxivPreprint02/28/202003/04/2020 19:09China, Shanghai ACE2clinical featuresFebruarykaletralaboratory resultsliverliver damagelopinavir/ritonavirsigns and symptomspathology patient-reportsmedrxivchina shanghaipreprint
Pathology, Patient reportsClinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019medRxivPreprint02/27/202003/04/2020 19:00China, Hubei, Wuhan ARDSchartsclinical featurescomorbiditylaboratory resultspneumoniaRT-PCRsigns and symptomsstatisticpathology patient-reportsmedrxivchina hubei wuhanpreprint
Patient reportsInterim Epidemiological and clinical characteristic of COVID-19 28 cases in South KoreaKCDCPeer-reviewed02/27/202003/04/2020 18:52South Korea chartsclinical featuressigns and symptomsSouth Koreatimeline chartstransmissionpatient-reportskcdcsouth-koreapeer-reviewed
PathologyThe neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patientsJMVPeer-reviewed02/27/202003/04/2020 18:44China ACE2braincell susceptibilityclinical featuresdisseminationMERSnervous systemSARS-CoVpathologyjmvchinapeer-reviewed
Pathology, Patient reportsNeurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series studymedRxivPreprint02/25/202003/04/2020 18:36China cerebrovascular diseaseclinical featuresFebruarylaboratory resultsmusclesneurologypathology patient-reportsmedrxivchinapreprint
Patient reportsClinical characteristics of 50466 patients with 2019-nCoV infectionmedRxivPreprint02/25/202003/04/2020 18:28China clinical featuresmassive studymeta-analysisstatisticpatient-reportsmedrxivchinapreprint
Statistics and forecastsCharacteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA NetworkPeer-reviewed02/24/202003/04/2020 13:08China massive studyprognosisSARS-CoVtimeline chartstransmissionstatistics-and-forecasts epidemiologyjama-networkchinapeer-reviewed
Patient reportsField Briefing: Diamond Princess COVID-19 Cases, 20 Feb UpdateNIIDPeer-reviewed02/21/202003/04/2020 12:49Diamond Princess (ship), Japan asymptomaticclinical featuresDiamond PrincessepidemiologyFebruaryJapansigns and symptomstimeline chartstransmissionpatient-reportsniiddiamond-princess-ship japanpeer-reviewed
Patient reportsPresumed Asymptomatic Carrier Transmission of COVID-19JAMA NetworkPeer-reviewed02/21/202003/04/2020 12:59China, Hubei, Wuhan asymptomaticepidemiologyfamilyFebruarylaboratory resultssigns and symptomstimeline chartstransmissionpatient-reportsjama-networkchina hubei wuhanpeer-reviewed
Pathology, Patient reportsEvidence for gastrointestinal infection of SARS-CoV-2medRxivPreprint03/04/202003/04/2020 12:53China clinical featuresgastrologyhistologylaboratory resultsRT-PCRstoolstudyviral loadpathology patient-reportsmedrxivchinapreprint
Patient reportsField Briefing: Diamond Princess COVID-19 CasesNIIDPeer-reviewed02/19/202003/04/2020 12:49Diamond Princess (ship), Japan clinical featuresDiamond PrincessepidemiologyFebruaryJapansigns and symptomstimeline chartstransmissionpatient-reportsniiddiamond-princess-ship japanpeer-reviewed
Pathology, Patient reportsCoronavirus immunoreactivity in individuals with a recent onset of psychotic symptomsPubmedPeer-reviewed06/02/200903/04/2020 11:20USA bipolar disorderclinical featuresimmunologyold studyschizophreniapathology patient-reportspubmedusapeer-reviewed
Pathology, Patient reportsClinical characteristics of 140 patients infected by SARS‐CoV‐2 in Wuhan, ChinaWileyPeer-reviewed02/19/202002/27/2020 06:30China, Hubei, Wuhan ACE2allergyclinical featuresCTeosinophilFebruarylaboratory resultspneumoniarisk factorsigns and symptomssmokingpathology patient-reportswileychina hubei wuhanpeer-reviewed
Pathology, Patient reportsClinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case seriesBMJPeer-reviewed02/19/202002/27/2020 06:24China, Zhejiang arbidolclinical featurescorticosteroidsCTFebruarygamma globulininterferon alphakaletralaboratory resultslopinavir/ritonavirpneumoniasigns and symptomstreatmentpathology patient-reportsbmjchina zhejiangpeer-reviewed
Patient reportsA familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation periodOxford AcademicPeer-reviewed02/18/202002/27/2020 05:54China, Shanghai asymptomaticclinical featuresepidemiologyfamilyFebruaryincubation periodlaboratory resultsRT-PCRsigns and symptomstransmissionpatient-reportsoxford-academicchina shanghaipeer-reviewed
Pathology, Patient reportsPathological findings of COVID-19 associated with acute respiratory distress syndromeThe LancetPeer-reviewed02/17/202002/27/2020 05:44China, Hubei, Wuhan ARDSclinical featuresFebruaryhistologylaboratory resultspathologypneumoniasigns and symptomstimeline chartstreatmentpathology patient-reportsthe-lancetchina hubei wuhanpeer-reviewed
Patient reportsCase of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCRJKMSPeer-reviewed02/14/202002/27/2020 05:34South Korea antiviralclinical featuresCTFebruarykaletralaboratory resultslopinavir/ritonavirpneumoniaRT-PCRsigns and symptomsSouth Koreatimeline chartstreatmentviral loadpatient-reportsjkmssouth-koreapeer-reviewed
Pathology, Patient reportsSevere Acute Respiratory Disease in a Huanan Seafood Market Worker: Images of an Early CasualtyRSNAPeer-reviewed02/14/202002/27/2020 05:29China, Hubei, Wuhan clinical featuresCTFebruarylaboratory resultspneumoniasigns and symptomspathology patient-reportsrsnachina hubei wuhanpeer-reviewed
Patient reportsNovel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in ChinaJAMA NetworkPeer-reviewed02/14/202002/27/2020 04:36China childrenclinical featuresFebruaryinfantsprognosissigns and symptomspatient-reportsjama-networkchinapeer-reviewed
Patient reportsThe Epidemiological Characteristics of an Outbreak of 2019 NovelCoronavirus Diseases (COVID-19)China CDCPeer-reviewed02/14/202002/27/2020 04:27China clinical featuresepidemiologyFebruarymassive studysigns and symptomsstatistictimeline chartsWuhanpatient-reportschina-cdcchinapeer-reviewed
Patient reportsFirst imported case of 2019 novel coronavirus in Canada, presenting as mild pneumoniaThe LancetPeer-reviewed02/13/202002/27/2020 04:22Canada, Ontario, Toronto Canadaclinical featuresCTFebruarylaboratory resultspneumoniasigns and symptomspatient-reportsthe-lancetcanada ontario torontopeer-reviewed
Patient reportsClinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical recordsThe LancetPeer-reviewed02/12/202002/27/2020 04:10China, Hubei, Wuhan clinical featuresCTFebruarylaboratory resultsneonatal outcomespneumoniapregnancypregnantsigns and symptomstreatmentvertical transmissionpatient-reportsthe-lancetchina hubei wuhanpeer-reviewed
Patient reportsJourney of a Thai Taxi Driver and Novel CoronavirusNEJMPeer-reviewed02/12/202002/27/2020 04:06Bangkok, Taiwan clinical featuresfamilysigns and symptomsTaiwanpatient-reportsnejmbangkok taiwanpeer-reviewed
Patient reportsA Locally Transmitted Case of SARS-CoV-2 Infection in TaiwanNEJMPeer-reviewed02/12/202002/27/2020 03:39Taiwan clinical featuresCTFebruarypneumoniasigns and symptomsTaiwantransmissiontravelertreatmentpatient-reportsnejmtaiwanpeer-reviewed
Patient reportsThe first 2019 novel coronavirus case in NepalThe LancetPeer-reviewed02/10/202002/27/2020 03:33Kathmandu, Nepal clinical featuresCTFebruaryNepalpneumoniarecoveredpatient-reportsthe-lancetkathmandu nepalpeer-reviewed
Patient reportsEpidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, ChinaJAMA NetworkPeer-reviewed02/07/202002/27/2020 03:26Beijing, China Beijingclinical featuresCTlaboratory resultspneumoniasigns and symptomspatient-reportsjama-networkbeijing chinapeer-reviewed
Patient reportsClinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA NetworkPeer-reviewed02/07/202002/27/2020 03:20China, Hubei, Wuhan clinical featuresCTFebruarylaboratory resultspneumoniasigns and symptomstimeline chartstreatmentWuhanpatient-reportsjama-networkchina hubei wuhanpeer-reviewed
Patient reportsFirst Case of 2019 Novel Coronavirus in the United StatesNEJMPeer-reviewed01/31/202002/27/2020 03:10Snohom-ish County, USA, Washington clinical featuresCTJanuarylaboratory resultspneumoniasigns and symptomstravelertreatmentUSApatient-reportsnejmsnohom-ish-county usa washingtonpeer-reviewed
Patient reportsEpidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive studyThe LancetPeer-reviewed01/30/202002/27/2020 03:03China, Hubei, Wuhan clinical featuresCTJanuarylaboratory resultssigns and symptomstreatmentWuhanpatient-reportsthe-lancetchina hubei wuhanpeer-reviewed
Patient reportsTransmission of 2019-nCoV Infection from an Asymptomatic Contact in GermanyNEJMPeer-reviewed02/27/202002/27/2020 02:54China, Germany, Munich, Shanghai asymptomaticGermanyJanuarysigns and symptomstransmissionpatient-reportsnejmchina germany munich shanghaipeer-reviewed
Patient reportsClinical features of patients infected with 2019 novel coronavirus in Wuhan, China (41 cases)The LancetPeer-reviewed01/24/202002/24/2020 02:53China, Hubei, Shenzhen, Wuhan clinical featuresCTJanuarylaboratory resultspneumoniaRT-PCRsigns and symptomstreatmentWuhanpatient-reportsthe-lancetchina hubei shenzhen wuhanpeer-reviewed
Patient reportsA familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission, a study of a family clusterThe LancetPeer-reviewed01/24/202002/24/2020 02:20China, Hubei, Shenzhen, Wuhan clinical featuresfamilyJanuarylaboratory resultspneumoniaRT-PCRsigns and symptomstransmissiontreatmentWuhanpatient-reportsthe-lancetchina hubei shenzhen wuhanpeer-reviewed